Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 - Product Image

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4402154
  • Report
  • 567 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • BioMarker Strategies LLC
  • Eventus Diagnostics Inc
  • MDxHealth SA
  • OTraces Inc.
  • Sysmex Corp
  • MORE
Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Lung Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • BioMarker Strategies LLC
  • Eventus Diagnostics Inc
  • MDxHealth SA
  • OTraces Inc.
  • Sysmex Corp
  • MORE
1 Table of Contents
2 Introduction
2.1 Lung Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Lung Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Lung Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Lung Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Lung Cancer Diagnostic Tests - Ongoing Clinical Trials
4 Lung Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Lung Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Lung Cancer Diagnostic Tests Companies and Product Overview
5.1 A&G Pharmaceutical Inc Company Overview
5.2 Abbott Diagnostics Company Overview
5.3 Abcodia Ltd Company Overview
5.4 Aberystwyth University Company Overview
5.5 Acobiom Company Overview
5.6 Advanced Marker Discovery SL Company Overview
5.7 Advpharma Inc Company Overview
5.8 AIT Austrian Institute of Technology GmbH Company Overview
5.9 Almac Diagnostics Ltd Company Overview
5.10 Arizona State University Company Overview
5.11 Armune BioScience Inc Company Overview
5.12 Aurelium BioPharma Inc. Company Overview
5.13 Avant Diagnostics, Inc. Company Overview
5.14 BARD1 Life Sciences Ltd Company Overview
5.15 Biocept Inc Company Overview
5.16 BioChain Institute Inc Company Overview
5.17 Biodesix Inc Company Overview
5.18 Biological Dynamics, Inc. Company Overview
5.19 BioMark Diagnostics Inc. Company Overview
5.20 BioMarker Strategies LLC Company Overview
5.21 BioNTech AG Company Overview
5.22 BioSystems International Company Overview
5.23 Cancer Genetics Inc Company Overview
5.24 Cancer Research Technology Ltd Company Overview
5.25 Cangen Biotechnologies Inc (Inactive) Company Overview
5.26 CDI Laboratories Inc Company Overview
5.27 Cellanyx Diagnostics, Inc. Company Overview
5.28 CellMax Life Company Overview
5.29 CeMines, Inc. (Inactive) Company Overview
5.30 Cepheid Company Overview
5.31 Ceres Nanosciences Inc Company Overview
5.32 Cernostics Inc. Company Overview
5.33 ChemImage Corp Company Overview
5.34 Children's Hospital Boston Company Overview
5.35 Clarient Inc Company Overview
5.36 Courtagen Life Sciences Inc Company Overview
5.37 DiagnoCure Inc. (Inactive) Company Overview
5.38 EDP Biotech Corporation Company Overview
5.39 Emory University Company Overview
5.40 Epic Sciences Inc Company Overview
5.41 Epigenomics AG Company Overview
5.42 Eventus Diagnostics Inc (Inactive) Company Overview
5.43 Exact Sciences Corp Company Overview
5.44 Exiqon A/S Company Overview
5.45 Exosomics Siena SpA Company Overview
5.46 Fahy Gurteen UK Ltd Company Overview
5.47 Fina Biotech SL Company Overview
5.48 French National Institute of Health and Medical Research Company Overview
5.49 Fresh Medical Laboratories Inc Company Overview
5.50 Gene Express, Inc. (Inactive) Company Overview
5.51 GeneCentric Diagnostics, Inc. Company Overview
5.52 Global Discovery Biosciences Corporation Company Overview
5.53 GlycoZym Company Overview
5.54 HalioDx SAS Company Overview
5.55 ImmunoCellular Therapeutics Ltd Company Overview
5.56 Imperial College London Company Overview
5.57 Insight Genetics Inc Company Overview
5.58 InterGenetics Inc Company Overview
5.59 IV Diagnostics, Inc. Company Overview
5.60 Janssen Biotech Inc Company Overview
5.61 Laboratorios SALVAT SA Company Overview
5.62 Louisville Bioscience, Inc. Company Overview
5.63 Mayo Clinic US Company Overview
5.64 MDNA Life Sciences Inc Company Overview
5.65 MDxHealth SA Company Overview
5.66 MEDITE Cancer Diagnostics Inc Company Overview
5.67 Memory Dx LLC Company Overview
5.68 Merrimack Pharmaceuticals Inc Company Overview
5.69 Metabolon Inc Company Overview
5.70 Metanomics Health GmbH Company Overview
5.71 MetaStat Inc Company Overview
5.72 Milagen Inc Company Overview
5.73 MiRXES Pte Ltd Company Overview
5.74 Nanocytomics LLC Company Overview
5.75 Nanopore Diagnostics, LLC Company Overview
5.76 NEOMICS Co Ltd Company Overview
5.77 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
5.78 Oncimmune (USA) LLC Company Overview
5.79 OncoCyte Corp Company Overview
5.80 Oncolome Diagnostics Inc (Inactive) Company Overview
5.81 Onconome, Inc. (Inactive) Company Overview
5.82 OncoStem Diagnostics Pvt. Ltd Company Overview
5.83 On-Q-ity, Inc. (Inactive) Company Overview
5.84 OPKO Health Inc Company Overview
5.85 Orion Genomics LLC Company Overview
5.86 OTraces Inc. Company Overview
5.87 Oxford Gene Technology Ltd Company Overview
5.88 PeriRx LLC Company Overview
5.89 PleX Diagnostics Inc (Inactive) Company Overview
5.90 Precision Biologics Inc Company Overview
5.91 PreMD Inc (Inactive) Company Overview
5.92 Proplex Technologies Llc Company Overview
5.93 Proteome Sciences Plc Company Overview
5.94 Proteomika Company Overview
5.95 Provista Diagnostics Inc Company Overview
5.96 Quest Diagnostics Inc Company Overview
5.97 Research Center Borstel Company Overview
5.98 Roche Diagnostics International Ltd Company Overview
5.99 Rosetta Genomics Ltd Company Overview
5.100 Roswell Park Cancer Institute Company Overview
5.101 Savicell Diagnostic Ltd. Company Overview
5.102 Siemens Healthcare GmbH Company Overview
5.103 Sienna Cancer Diagnostics Ltd Company Overview
5.104 Simon Fraser University Company Overview
5.105 Sividon Diagnostics GmbH Company Overview
5.106 SomaLogic Inc Company Overview
5.107 Southern Illinois University Carbondale Company Overview
5.108 Syndax Pharmaceuticals Inc Company Overview
5.109 Sysmex Corp Company Overview
5.110 The Wistar Institute Company Overview
5.111 Transgene SA Company Overview
5.112 TransGenic Inc Company Overview
5.113 Treos Bio Inc Company Overview
5.114 Trinity College Dublin Company Overview
5.115 Universal Diagnostics SL Company Overview
5.116 University of California San Francisco Company Overview
5.117 University of Chicago Company Overview
5.118 University of Colorado Company Overview
5.119 University of Maryland Company Overview
5.120 University of Queensland Company Overview
5.121 University of South Florida Company Overview
5.122 University of Strathclyde Company Overview
5.123 US Biomarkers Inc Company Overview
5.124 Vanderbilt University Company Overview
5.125 Ventana Medical Systems Inc Company Overview
5.126 Viomics Inc. Company Overview
5.127 VisionGate, Inc. Company Overview
5.128 Vitatex Inc. Company Overview
5.129 VolitionRX Ltd Company Overview
5.130 Weizmann Institute of Science Company Overview
5.131 XEPTAGEN SpA Company Overview
5.132 Zetiq Technologies Ltd Company Overview
6 Lung Cancer Diagnostic Tests - Recent Developments
6.1 Sep 07, 2017: OncoCyte Receives CLIA Certification for its Cancer Diagnostics Laboratory
6.2 Sep 06, 2017: Simple blood test opens door to new treatments for lung cancer patients
6.3 Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion
6.4 Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories
6.5 Sep 05, 2017: Seasoned Diagnostics Sales Executive Joins OncoCyte to Drive Commercialization and Future Sales Initiatives of DetermaVu, the Companys Novel Liquid Biopsy Lung Cancer Diagnostic
6.6 Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses
6.7 Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
6.8 Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results
6.9 Aug 31, 2017: MPI publishes Half-year Report for the first half of 2017
6.10 Aug 31, 2017: Sienna Cancer Diagnostics: Appendix 4E & 2017 Financial Report Release
6.11 Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
6.12 Aug 29, 2017: Todos Medical Appoints Dr. Meir Silver as Vice President of Clinical Research and Regulatory Affairs
6.13 Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer
6.14 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer
6.15 Aug 23, 2017: ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy
6.16 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
6.17 Aug 21, 2017: 20/20’s Lung Cancer Detection Technology Launches in China
6.18 Aug 21, 2017: Unique test to help detect lung cancer early
6.19 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories
6.20 Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results
6.21 Aug 14, 2017: ImmunoCellular Therapeutics Announces Second Quarter 2017 Financial Results
6.22 Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results
6.23 Aug 10, 2017: Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update
6.24 Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results
6.25 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update
6.26 Aug 08, 2017: Cynvenio Announces New LiquidBiopsy Test for PD-L1 Expression in Lung Cancer
6.27 Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results
6.28 Aug 07, 2017: BARD1 Life Sciences: Australian Patent Issued In Core Patent Family
6.29 Aug 07, 2017: OncoCyte Latest Lung Cancer Diagnostic Test Data Accepted for Slide Presentation at CHEST 2017 Annual Meeting
6.30 Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion
6.31 Aug 03, 2017: Insmed Reports Second Quarter 2017 Financial Results and Provides Business Update
6.32 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results
6.33 Aug 01, 2017: Proteome Sciences: Directorate changes
6.34 Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
6.35 Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
6.36 Jul 31, 2017: Veracyte Announces Second Quarter 2017 Financial Results
6.37 Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results
6.38 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017
6.39 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance
6.40 Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group
6.41 Jul 25, 2017: Roche gains CE label expansion for companion diagnostic to identify ALK-positive non-small cell lung cancer patients
6.42 Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017
6.43 Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK
6.44 Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook
6.45 Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests
6.46 Jul 24, 2017: Oncocyte Analytical Validation Study of Its Lung Cancer Diagnostic Test Confirms Previously Published Results
6.47 Jul 21, 2017: GSK announces Board and Committee changes
6.48 Jul 18, 2017: Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
6.49 Jul 18, 2017: LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center
6.50 Jul 18, 2017: Hans E. Bishop to Join Agilent's Board of Directors
6.51 Jul 18, 2017: Lew Titterton re-joins ITUS Board of Directors
6.52 Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin
6.53 Jul 13, 2017: New ACRF Research Centre Targets Early Detection Of Lung Cancer
6.54 Jul 13, 2017: BioTime Subsidiary AgeX Therapeutics Appoints Aubrey de Grey, Ph.D. as VP of New Technology Discovery
6.55 Jul 10, 2017: Lung Cancer: VeriStrat Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy
6.56 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China
6.57 Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017
6.58 Jul 03, 2017: Premaitha Health Litigation Update
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Lung Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Lung Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Lung Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Lung Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Lung Cancer Companies - Pipeline Products by Stage of Development
Table 7: Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Onco 88 - Lung Cancer - Product Status
Table 10: Onco 88 - Lung Cancer - Product Description
Table 11: OncoStain 88 - Lung Cancer - Product Status
Table 12: OncoStain 88 - Lung Cancer - Product Description
Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 14: ARCHITECT c4000 System - NSE Assay - Product Status
Table 15: ARCHITECT c4000 System - NSE Assay - Product Description
Table 16: ARCHITECT c8000 System - NSE Assay - Product Status
Table 17: ARCHITECT c8000 System - NSE Assay - Product Description
Table 18: ARCHITECT ci4100 Integrated System - NSE Assay - Product Status
Table 19: ARCHITECT ci4100 Integrated System - NSE Assay - Product Description
Table 20: ARCHITECT ci8200 Integrated System - NSE Assay - Product Status
Table 21: ARCHITECT ci8200 Integrated System - NSE Assay - Product Description
Table 22: ARCHITECT i1000SR System - NSE Assay - Product Status
Table 23: ARCHITECT i1000SR System - NSE Assay - Product Description
Table 24: ARCHITECT i2000SR - Neuron-Specific Enolase Assay - Product Status
Table 25: ARCHITECT i2000SR - Neuron-Specific Enolase Assay - Product Description
Table 26: PRAME Antigen Lung Cancer Assay - Product Status
Table 27: PRAME Antigen Lung Cancer Assay - Product Description
Table 28: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Diagnostic Assay - Lung Cancer - Product Status
Table 30: Diagnostic Assay - Lung Cancer - Product Description
Table 31: MCM Test - Lung Cancer - Product Status
Table 32: MCM Test - Lung Cancer - Product Description
Table 33: Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Biomarker Test - Lung Cancer - Product Status
Table 35: Diagnostic Biomarker Test - Lung Cancer - Product Description
Table 36: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Companion Diagnostic Test - Lung Cancer - Product Status
Table 38: Companion Diagnostic Test - Lung Cancer - Product Description
Table 39: Diagnostic/Prognostic Assay - Lung Cancer - Product Status
Table 40: Diagnostic/Prognostic Assay - Lung Cancer - Product Description
Table 41: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Predictive Diagnostic Test - Lung Cancer - Product Status
Table 43: Predictive Diagnostic Test - Lung Cancer - Product Description
Table 44: Prognostic Test - Lung Cancer - Product Status
Table 45: Prognostic Test - Lung Cancer - Product Description
Table 46: Advpharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Lung Cancer Prognostic Assay - Product Status
Table 48: Lung Cancer Prognostic Assay - Product Description
Table 49: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Biomarker Assay - Lung Cancer - Product Status
Table 51: Biomarker Assay - Lung Cancer - Product Description
Table 52: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Prognostic Test - Early Stage Lung Cancer - Product Status
Table 54: Prognostic Test - Early Stage Lung Cancer - Product Description
Table 55: Prognostic Test - NSCLC - Product Status
Table 56: Prognostic Test - NSCLC - Product Description
Table 57: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Diagnostic Test - Lung Cancer - Product Status
Table 59: Diagnostic Test - Lung Cancer - Product Description
Table 60: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Diagnostic Test - Lung Cancer - Product Status
Table 62: Diagnostic Test - Lung Cancer - Product Description
Table 63: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Lung Cancer Screening Test - Product Status
Table 65: Lung Cancer Screening Test - Product Description
Table 66: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 67: TheraLink Assay - Non-Small Cell Lung Cancer - Product Status
Table 68: TheraLink Assay - Non-Small Cell Lung Cancer - Product Description
Table 69: BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 70: BARD1 Lung Cancer Test - Product Status
Table 71: BARD1 Lung Cancer Test - Product Description
Table 72: Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Companion Diagnostic Target Selector Test - SCLC - Product Status
Table 74: Companion Diagnostic Target Selector Test - SCLC - Product Description
Table 75: MicroRNA Test - Lung Cancer - Product Status
Table 76: MicroRNA Test - Lung Cancer - Product Description
Table 77: BioChain Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Blood - Based Lung Cancer Test - Product Status
Table 79: Blood - Based Lung Cancer Test - Product Description
Table 80: BioChain Institute Inc - Ongoing Clinical Trials Overview
Table 81: Blood - Based Lung Cancer Test - BioChain Clinical Trial on novel, blood-based lung cancer test
Table 82: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 83: PD-L1 Blood Based Diagnostic Test - Product Status
Table 84: PD-L1 Blood Based Diagnostic Test - Product Description
Table 85: TAm-Seq NGS Lung Cancer Test - Product Status
Table 86: TAm-Seq NGS Lung Cancer Test - Product Description
Table 87: VeriStrat - NSCLC - Product Status
Table 88: VeriStrat - NSCLC - Product Description
Table 89: Biological Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 90: OncoState Lung Assay - Product Status
Table 91: OncoState Lung Assay - Product Description
Table 92: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Metabolomics-based Diagnostic Assay - Lung Cancer - Product Status
Table 94: Metabolomics-based Diagnostic Assay - Lung Cancer - Product Description
Table 95: BioMark Diagnostics Inc. - Ongoing Clinical Trials Overview
Table 96: Metabolomics-based Diagnostic Assay - Lung Cancer - Clinical Trial with Patented Non-invasive, Urine-based Assay to Measure Response to Treatment for Lung Cancer
Table 97: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Ex Vivo Biomarker Test - Lung Cancer - Product Status
Table 99: Ex Vivo Biomarker Test - Lung Cancer - Product Description
Table 100: PathMAP NSCLC - Product Status
Table 101: PathMAP NSCLC - Product Description
Table 102: BioNTech AG Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Lung Cancer Screening Test - Product Status
Table 104: Lung Cancer Screening Test - Product Description
Table 105: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
Table 106: QuantiPlasma Antibody Based Test - Lung Cancer - Product Status
Table 107: QuantiPlasma Antibody Based Test - Lung Cancer - Product Description
Table 108: Cancer Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Companion Diagnostic Test - Tavocept - Product Status
Table 110: Companion Diagnostic Test - Tavocept - Product Description
Table 111: Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 112: MCM Test - Lung Cancer - Product Status
Table 113: MCM Test - Lung Cancer - Product Description
Table 114: Cangen Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Diagnostic Test - Early Stage Lung Cancer - Product Status
Table 116: Diagnostic Test - Early Stage Lung Cancer - Product Description
Table 117: CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Diagnostic Test - Lung Cancer - Product Status
Table 119: Diagnostic Test - Lung Cancer - Product Description
Table 120: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 121: Cellanyx Test - Lung Cancer - Product Status
Table 122: Cellanyx Test - Lung Cancer - Product Description
Table 123: CellMax Life Pipeline Products & Ongoing Clinical Trials Overview
Table 124: Cellmax - Lung Cancer - Product Status
Table 125: Cellmax - Lung Cancer - Product Description
Table 126: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 127: CellCorrect LAb Test For Lung Cancer - Product Status
Table 128: CellCorrect LAb Test For Lung Cancer - Product Description
Table 129: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 130: Xpert Lung CA Early Detection Test - Product Status
Table 131: Xpert Lung CA Early Detection Test - Product Description
Table 132: Xpert OncoScreen Lung Cancer Assay - Product Status
Table 133: Xpert OncoScreen Lung Cancer Assay - Product Description
Table 134: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 135: Nanotrap Lung Cancer Biomarker Test - Product Status
Table 136: Nanotrap Lung Cancer Biomarker Test - Product Description
Table 137: Cernostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 138: TissueCypher Lung Cancer Test - Product Status
Table 139: TissueCypher Lung Cancer Test - Product Description
Table 140: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 141: Prognostic Test - Lung Cancer - Product Status
Table 142: Prognostic Test - Lung Cancer - Product Description
Table 143: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 144: Collagen XXIII Biomarker Assay - NSCLC - Product Status
Table 145: Collagen XXIII Biomarker Assay - NSCLC - Product Description
Table 146: Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 147: ALK PCR Test - NSCLC - Product Status
Table 148: ALK PCR Test - NSCLC - Product Description
Table 149: PulmoTax - Product Status
Table 150: PulmoTax - Product Description
Table 151: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 152: Lung Cancer Diagnostic Panel - Product Status
Table 153: Lung Cancer Diagnostic Panel - Product Description
Table 154: DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 155: Diagnostic Test - Lung Cancer - Product Status
Table 156: Diagnostic Test - Lung Cancer - Product Description
Table 157: EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 158: PulmoMarker Test - Product Status
Table 159: PulmoMarker Test - Product Description
Table 160: Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table 161: Biomarker Assay - Small Cell Lung Cancer - Product Status
Table 162: Biomarker Assay - Small Cell Lung Cancer - Product Description
Table 163: Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 164: PD-L1 Blood Test - Product Status
Table 165: PD-L1 Blood Test - Product Description
Table 166: Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview
Table 167: Epi proLung BL 1.0 - Blood Plasma - Product Status

List of Figures
Figure 1: Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Lung Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Lung Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Lung Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Lung Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • A&G Pharmaceutical Inc
  • Abbott Diagnostics
  • Abcodia Ltd
  • Aberystwyth University
  • Acobiom
  • Advanced Marker Discovery SL
  • Advpharma Inc
  • AIT Austrian Institute of Technology GmbH
  • Almac Diagnostics Ltd
  • Arizona State University
  • Armune BioScience Inc
  • Aurelium BioPharma Inc.
  • Avant Diagnostics, Inc.
  • BARD1 Life Sciences Ltd
  • Biocept Inc
  • BioChain Institute Inc
  • Biodesix Inc
  • Biological Dynamics, Inc.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies LLC
  • BioNTech AG
  • BioSystems International
  • Cancer Genetics Inc
  • Cancer Research Technology Ltd
  • Cangen Biotechnologies Inc
  • CDI Laboratories Inc
  • Cellanyx Diagnostics, Inc.
  • CellMax Life
  • CeMines, Inc.
  • Cepheid
  • Ceres Nanosciences Inc
  • Cernostics Inc.
  • ChemImage Corp
  • Children's Hospital Boston
  • Clarient Inc
  • Courtagen Life Sciences Inc
  • DiagnoCure Inc.
  • EDP Biotech Corporation
  • Emory University
  • Epic Sciences Inc
  • Epigenomics AG
  • Eventus Diagnostics Inc
  • Exact Sciences Corp
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • Fina Biotech SL
  • French National Institute of Health and Medical Research
  • Fresh Medical Laboratories Inc
  • Gene Express, Inc.
  • GeneCentric Diagnostics, Inc.
  • Global Discovery Biosciences Corporation
  • GlycoZym
  • HalioDx SAS
  • ImmunoCellular Therapeutics Ltd
  • Imperial College London
  • Insight Genetics Inc
  • InterGenetics Inc
  • IV Diagnostics, Inc.
  • Janssen Biotech Inc
  • Laboratorios SALVAT SA
  • Louisville Bioscience, Inc.
  • Mayo Clinic US
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • MEDITE Cancer Diagnostics Inc
  • Memory Dx LLC
  • Merrimack Pharmaceuticals Inc
  • Metabolon Inc
  • Metanomics Health GmbH
  • MetaStat Inc
  • Milagen Inc
  • MiRXES Pte Ltd
  • Nanocytomics LLC
  • Nanopore Diagnostics, LLC
  • NEOMICS Co Ltd
  • Novel Bio-spectrum Technologies Inc
  • Oncimmune (USA) LLC
  • OncoCyte Corp
  • Oncolome Diagnostics Inc
  • Onconome, Inc.
  • OncoStem Diagnostics Pvt. Ltd
  • On-Q-ity, Inc.
  • OPKO Health Inc
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Gene Technology Ltd
  • PeriRx LLC
  • PleX Diagnostics Inc
  • Precision Biologics Inc
  • PreMD Inc
  • Proplex Technologies Llc
  • Proteome Sciences Plc
  • Proteomika
  • Provista Diagnostics Inc
  • Quest Diagnostics Inc
  • Research Center Borstel
  • Roche Diagnostics International Ltd
  • Rosetta Genomics Ltd
  • Roswell Park Cancer Institute
  • Savicell Diagnostic Ltd.
  • Siemens Healthcare GmbH
  • Sienna Cancer Diagnostics Ltd
  • Simon Fraser University
  • Sividon Diagnostics GmbH
  • SomaLogic Inc
  • Southern Illinois University Carbondale
  • Syndax Pharmaceuticals Inc
  • Sysmex Corp
  • The Wistar Institute
  • Transgene SA
  • TransGenic Inc
  • Treos Bio Inc
  • Trinity College Dublin
  • Universal Diagnostics SL
  • University of California San Francisco
  • University of Chicago
  • University of Colorado
  • University of Maryland
  • University of Queensland
  • University of South Florida
  • University of Strathclyde
  • US Biomarkers Inc
  • Vanderbilt University
  • Ventana Medical Systems Inc
  • Viomics Inc.
  • VisionGate, Inc.
  • Vitatex Inc.
  • VolitionRX Ltd
  • Weizmann Institute of Science
  • XEPTAGEN SpA
  • Zetiq Technologies Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll